Sheff have you ever liked a stock long enough to hold for years? I am feeling that way now about IMGN. But for right now short term they have an investor conference the 12th, IMGN901 sclc interim data should be in august (6 months after their full enrollment.) And phase 3 data for TDM-1 first line should be year end. Doctors seem to love this drug and I posted an article yesterday how it was being used for another cancer in a guys intestines. I think earnings will surprise some people even though they receive a small royalty percentage. When approved for first line could generate a nice yearly income (around 300 mil for IMGN). From what I am seeing and hearing I really doubt it would not be the best first line treatment on the market once approved. I would hope the FDA moves quick as possible on it considering the benefits to patients.
I always told myself never to fall in love with a stock, but feel like in 5 years this stock could be sitting nicely if not bought out. I want to just trade it but would hate it to take off and not look back when I am out. I traded before approval and after approval but now I am actually thinking about holding and adding to my position with other profits. Whats your thoughts? Thanks
News 
Market Data 
Discover 
AI
